Changsheng Xu
-
- Renin-Angiotensin System Studies 6
-
- MicroRNA in disease regulation 4
-
- Pulmonary Hypertension Research and Treatments 10
-
- Retinoids in leukemia and cellular processes 5
- Peroxisome Proliferator-Activated Receptors 4
- Angiogenesis and VEGF in Cancer 4
-
- Hormonal Regulation and Hypertension 4
-
- Coagulation, Bradykinin, Polyphosphates, and Angioedema 5
- Journals
- Molecular and Cellular Biochemistry (5 papers)International Journal of Molecular Medicine (3 papers)Oxidative Medicine and Cellular Longevity (2 papers)
- Partner nations
- China
In The Last Decade
Changsheng Xu
51 papers receiving 685 citations
Peers
Comparison fields: 5 of 85
- Cardiology and Cardiovascular Medicine 161
- Cancer Research 78
- Pulmonary and Respiratory Medicine 163
- Molecular Biology 320
- Endocrinology, Diabetes and Metabolism 76
Countries citing papers authored by Changsheng Xu
This map shows the geographic impact of Changsheng Xu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Changsheng Xu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Changsheng Xu more than expected).
Fields of papers citing papers by Changsheng Xu
This network shows the impact of papers produced by Changsheng Xu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Changsheng Xu. The network helps show where Changsheng Xu may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Changsheng Xu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2023 | 2 | |
| 2 | 2023 | 2 | |
| 3 | 2023 | 11 | |
| 4 | 2022 | 30 | |
| 5 | 2022 | 12 | |
| 6 | 2020 | 8 | |
| 7 | 2020 | 13 | |
| 8 | 2018 | 2 | |
| 9 | 2018 | 5 | |
| 10 | 2018 | 46 | |
| 11 | 2016 | 32 | |
| 12 | 2014 | 13 | |
| 13 | 2014 | 14 | |
| 14 | 2014 | 9 | |
| 15 | 2014 | 17 | |
| 16 | Effects of adipose tissue-derived mesenchymal stem cells on calcium channels of pulmonary artery in rats with pulmonary arterial hypertension induced by monocrotaline | 2013 | 1 |
| 17 | 2013 | 14 | |
| 18 | 2013 | 11 | |
| 19 | 2011 | 12 | |
| 20 | 2009 | 17 |
About Changsheng Xu
Changsheng Xu is a scholar working on Cardiology and Cardiovascular Medicine, Cancer Research and Genetics, having authored 54 papers that have together received 692 indexed citations. Recurring topics across this work include Pulmonary Hypertension Research and Treatments (10 papers), Renin-Angiotensin System Studies (6 papers), Retinoids in leukemia and cellular processes (5 papers), Coagulation, Bradykinin, Polyphosphates, and Angioedema (5 papers), MicroRNA in disease regulation (4 papers), Peroxisome Proliferator-Activated Receptors (4 papers), Angiogenesis and VEGF in Cancer (4 papers) and Hormonal Regulation and Hypertension (4 papers). The work is most often cited by research in Cardiology and Cardiovascular Medicine (161 citations), Cancer Research (78 citations) and Pulmonary and Respiratory Medicine (163 citations). Changsheng Xu has collaborated with scholars based in China. Frequent co-authors include Liangdi Xie, Jinxiu Lin, Dajun Chai, Guili Lian, Hong Xie, Huajun Wang, Haifeng Chen, Feng Peng, Jin-Zhang Zeng and Li Luo. Their work appears in journals such as Molecular and Cellular Biochemistry, International Journal of Molecular Medicine, Oxidative Medicine and Cellular Longevity, Life Sciences and Clinical and Experimental Hypertension.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.